Ekso Bionics Holdings (LTS:0IFR) 3-Year EBITDA Growth Rate : 23.20% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Ekso Bionics Holdings 3-Year EBITDA Growth Rate?

Ekso Bionics Holdings's EBITDA per Share for the three months ended in Mar. 2024 was $-0.17.

During the past 3 years, the average EBITDA Per Share Growth Rate was 23.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 30.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 11.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 12 years, the highest 3-Year average EBITDA Per Share Growth Rate of Ekso Bionics Holdings was 51.30% per year. The lowest was -651.60% per year. And the median was 31.15% per year.

Competitive Comparison of Ekso Bionics Holdings's 3-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, Ekso Bionics Holdings's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ekso Bionics Holdings's 3-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ekso Bionics Holdings's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Ekso Bionics Holdings's 3-Year EBITDA Growth Rate falls into.

Ekso Bionics Holdings 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Ekso Bionics Holdings (LTS:0IFR) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Ekso Bionics Holdings 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Ekso Bionics Holdings's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Ekso Bionics Holdings (LTS:0IFR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ekso Bionics Holdings Inc (LTS:0IFR) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

EKSO:USA 23E2:Germany

Address

101 Glacier Point, Suite A, San Rafael, CA, USA, 94901

Website

https://www.eksobionics.com

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.

Ekso Bionics Holdings (LTS:0IFR) Headlines

No Headlines